糖尿病、血脂异常和心血管疾病的新型分子。
Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease.
机构信息
Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.
出版信息
Int J Mol Sci. 2023 Feb 17;24(4):4029. doi: 10.3390/ijms24044029.
Abstract
The purpose of this Special Issue is to present the impact in clinical practice as well as in medical research of novel molecules that have been introduced in the treatment of diabetes mellitus, dyslipidaemia, and cardiovascular disease [...].
摘要
本特刊的目的是展示新型分子在糖尿病、血脂异常和心血管疾病治疗中引入后对临床实践和医学研究的影响[... ]。
相似文献
1
Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease.糖尿病、血脂异常和心血管疾病的新型分子。
Int J Mol Sci. 2023 Feb 17;24(4):4029. doi: 10.3390/ijms24044029.
2
Treatment of dyslipidemia in patients with diabetes mellitus.糖尿病患者的血脂异常治疗。
Pharmacol Rep. 2005;57 Suppl:10-9.
3
[Diabetes and dyslipidemia: Why are they so closely related?].[糖尿病与血脂异常：为何它们关系如此密切？]
Vnitr Lek. 2016 Fall;62(11):908-911.
4
Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia.低剂量阿托伐他汀12个月干预对2型糖尿病合并血脂异常患者脉搏波速度的影响。
Diab Vasc Dis Res. 2019 Jan;16(1):38-46. doi: 10.1177/1479164118805320. Epub 2018 Oct 17.
5
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.欧洲心血管疾病一级预防中致动脉粥样硬化性血脂异常的患病率及治疗情况：EURIKA横断面观察性研究
BMC Cardiovasc Disord. 2017 Jun 17;17(1):160. doi: 10.1186/s12872-017-0591-5.
6
"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.“不打破就不修复”：对 ACCORD 血脂研究正反结果的评论。
Cardiovasc Diabetol. 2010 Jun 15;9:24. doi: 10.1186/1475-2840-9-24.
7
Treating Dyslipidemias in the Primary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults with Diabetes Mellitus.治疗老年糖尿病患者动脉粥样硬化性心血管疾病一级预防中的血脂异常
Clin Geriatr Med. 2020 Aug;36(3):457-476. doi: 10.1016/j.cger.2020.04.006. Epub 2020 Apr 17.
8
Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.糖尿病患者的血脂异常、肾脏疾病和心血管疾病。
Rev Diabet Stud. 2013 Summer-Fall;10(2-3):88-100. doi: 10.1900/RDS.2013.10.88. Epub 2013 Aug 10.
9
Mechanisms and Treatment of Dyslipidemia in Diabetes.糖尿病血脂异常的发病机制与治疗。
Curr Cardiol Rep. 2021 Mar 2;23(4):26. doi: 10.1007/s11886-021-01455-w.
10
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.2 型糖尿病患者降脂治疗的新治疗选择。
Acta Diabetol. 2018 Mar;55(3):209-218. doi: 10.1007/s00592-017-1089-4. Epub 2017 Dec 19.
引用本文的文献
1
Metabolomics and Antioxidant Activity of Valonea from Produced in Different Geographical Regions in China.中国不同地理区域产橡椀的代谢组学与抗氧化活性
Int J Mol Sci. 2025 Apr 11;26(8):3599. doi: 10.3390/ijms26083599.
2
Mitochondrial Dysfunction in Endothelial Cells: A Key Driver of Organ Disorders and Aging.内皮细胞中的线粒体功能障碍：器官疾病和衰老的关键驱动因素。
Antioxidants (Basel). 2025 Mar 21;14(4):372. doi: 10.3390/antiox14040372.
3
Solvent Fractionation and LC-MS Profiling, Antioxidant Properties, and α-Glucosidase Inhibitory Activity of ..的溶剂分级分离与液相色谱-质谱分析、抗氧化性能及α-葡萄糖苷酶抑制活性
Molecules. 2025 Feb 23;30(5):1021. doi: 10.3390/molecules30051021.
4
Comparison of incidence trends of early-onset and late-onset type 2 diabetes in the Asia-Pacific region, 1990-2021: a join point regression analysis based on the global burden of disease study 2021.1990 - 2021年亚太地区早发型和晚发型2型糖尿病发病率趋势比较：基于2021年全球疾病负担研究的Joinpoint回归分析
Front Endocrinol (Lausanne). 2025 Feb 19;16:1466428. doi: 10.3389/fendo.2025.1466428. eCollection 2025.
5
Elucidation of α-glucosidase inhibitory activity and UHPLC-ESI-QTOF-MS based metabolic profiling of endophytic fungi BRN05 isolated from seeds of king.从罗汉果种子中分离出的内生真菌BRN05的α-葡萄糖苷酶抑制活性解析及基于超高效液相色谱-电喷雾电离-四极杆飞行时间质谱的代谢谱分析
Front Fungal Biol. 2025 Jan 28;6:1447609. doi: 10.3389/ffunb.2025.1447609. eCollection 2025.
6
Using XGBoost for Predicting In-Stent Restenosis Post-DES Implantation: Role of Lymphocyte-to-Monocyte Ratio and Residual Cholesterol.使用XGBoost预测药物洗脱支架植入术后支架内再狭窄：淋巴细胞与单核细胞比值和残余胆固醇的作用
Int J Gen Med. 2024 Aug 9;17:3443-3452. doi: 10.2147/IJGM.S477053. eCollection 2024.
7
Study on the relationship between body mass index and blood pressure indices in children aged 7-17 during COVID-19.新冠疫情期间 7-17 岁儿童体重指数与血压指标关系的研究。
Front Public Health. 2024 Jun 19;12:1409214. doi: 10.3389/fpubh.2024.1409214. eCollection 2024.
8
Molecular Mechanisms of Metabolic Syndrome.代谢综合征的分子机制。
Int J Mol Sci. 2024 May 17;25(10):5452. doi: 10.3390/ijms25105452.
9
Therapeutic strategy of biological macromolecules based natural bioactive compounds of diabetes mellitus and future perspectives: A systematic review.基于生物大分子的糖尿病天然生物活性化合物治疗策略及未来展望：一项系统综述
Heliyon. 2024 Jan 7;10(2):e24207. doi: 10.1016/j.heliyon.2024.e24207. eCollection 2024 Jan 30.
10
Can Concurrent Fibrate Use Reduce Cardiovascular Risks among Moderate Chronic Kidney Disease Patients Undergoing Statin Therapy? A Cohort Study.在接受他汀类药物治疗的中度慢性肾脏病患者中，同时使用贝特类药物能否降低心血管疾病风险？一项队列研究。
J Clin Med. 2023 Dec 28;13(1):168. doi: 10.3390/jcm13010168.
本文引用的文献
1
Statins in Children, an Update.他汀类药物在儿童中的应用：更新。
Int J Mol Sci. 2023 Jan 10;24(2):1366. doi: 10.3390/ijms24021366.
2
Nicotinamide Mononucleotide Protects against Retinal Dysfunction in a Murine Model of Carotid Artery Occlusion.烟酰胺单核苷酸可预防颈动脉闭塞小鼠模型的视网膜功能障碍。
Int J Mol Sci. 2022 Nov 25;23(23):14711. doi: 10.3390/ijms232314711.
3
Tirzepatide: A Systematic Update.替尔泊肽：系统更新。
Int J Mol Sci. 2022 Nov 23;23(23):14631. doi: 10.3390/ijms232314631.
4
Synthesis of Glycolysis Inhibitor PFK15 and Its Synergistic Action with an Approved Multikinase Antiangiogenic Drug on Human Endothelial Cell Migration and Proliferation.糖酵解抑制剂 PFK15 的合成及其与一种已批准的多激酶抗血管生成药物对人内皮细胞迁移和增殖的协同作用。
Int J Mol Sci. 2022 Nov 18;23(22):14295. doi: 10.3390/ijms232214295.
5
New Molecules of Diterpene Origin with Inhibitory Properties toward α-Glucosidase.具有α-葡萄糖苷酶抑制活性的二萜类新分子。
Int J Mol Sci. 2022 Nov 4;23(21):13535. doi: 10.3390/ijms232113535.
6
Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure.探讨沙库巴曲缬沙坦在心力衰竭中的现代治疗选择和结局。
Int J Mol Sci. 2022 Sep 26;23(19):11336. doi: 10.3390/ijms231911336.
7
Nicotinamide Mononucleotide Prevents Retinal Dysfunction in a Mouse Model of Retinal Ischemia/Reperfusion Injury.烟酰胺单核苷酸可预防视网膜缺血/再灌注损伤小鼠模型的视网膜功能障碍。
Int J Mol Sci. 2022 Sep 23;23(19):11228. doi: 10.3390/ijms231911228.
8
Metabolic and cardiovascular benefits of GLP-1 agonists, besides the hypoglycemic effect (Review).胰高血糖素样肽-1激动剂除降血糖作用外的代谢和心血管益处（综述）
Exp Ther Med. 2020 Sep;20(3):2396-2400. doi: 10.3892/etm.2020.8714. Epub 2020 May 5.
Zotero 插件